Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gerresheimer AGGRRMF -7.99%56 Cash Ratio is 0.14 as of Nov. 2025, which is 7% below its 10-year median of 0.15. GuruFocus rates GRRMF with a GF Score™ of 56/100 and a GF Value™ of $196.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 841 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 88.94% on this metric.
Gerresheimer AG has a Cash Ratio of 0.14. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Gerresheimer AG's Cash Ratio or its related term are showing as below:
GRRMF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.15 Max: 0.45
Current: 0.14
During the past 13 years, Gerresheimer AG's highest Cash Ratio was 0.45. The lowest was 0.11. And the median was 0.15.
GRRMF's Cash Ratio is ranked worse than 88.94% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.98
vs GRRMF: 0.14
Gerresheimer AG (OTCPK:GRRMF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Gerresheimer AG Cash Ratio Related Terms
Gerresheimer AG Cash Ratio Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a Cash Ratio of 0.14 as of Nov. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Gerresheimer AG and its competitors. This is near median its historical median of 0.15. Over the past decade, Gerresheimer AG's Cash Ratio has ranged from 0.11 to 0.45. According to the industry distribution chart, Gerresheimer AG ranks #748 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 88.9%.
Is Gerresheimer AG's Cash Ratio too high?
Gerresheimer AG's current Cash Ratio of 0.14 is near median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.45. The Medical Devices & Instruments industry median Cash Ratio is 0.98. Gerresheimer AG's value of 0.14 is 85.7% below this industry median. Based on the distribution chart, Gerresheimer AG ranks #748 out of 841 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gerresheimer AG has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Cash Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #748 out of 841 companies for Cash Ratio. This places Gerresheimer AG in the lower half of its industry. The industry median Cash Ratio is 0.98. Gerresheimer AG's value of 0.14 is 85.7% below this benchmark. Historically, Gerresheimer AG's own Cash Ratio has ranged from 0.11 to 0.45 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 0.98, Gerresheimer AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.98, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current Cash Ratio of 0.14 is 85.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current Cash Ratio is 0.14, which is near median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $196.74, compared to a current price of $29.15 — trading 85.2% below its estimated fair value. The current Cash Ratio is 0.14, which is near median its 10-year median of 0.15 and 85.7% below the Medical Devices & Instruments industry median of 0.98. Gerresheimer AG's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Cash Ratio is 0.14 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $29.15 is trading 85.2% below its estimated GF Value™ of $196.74.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
Cash Ratio: 0.14 (near median its 10-year median of 0.15)
GF Value™: $196.74 vs. price of $29.15 (85.2% below fair value)
Industry Position: 85.7% below the Medical Devices & Instruments median (#748 of 841)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
56GF Score
Get the complete analysis for GRRMF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
